PharmaFluidics Raises 2.7 Million Euros for Funding

March 7, 2017
Lewis Botcherby
The Column
Volume 13, Issue 4
Page Number: 6

PharmaFluidics has announced an additional 2.7 million Euros worth of funding to support its commercial launch and expand its analytical applications portfolio to biomarkers, diagnostics, and drug development.

PharmaFluidics has announced an additional 2.7 million Euros worth of funding to support its commercial launch and expand its analytical applications portfolio to biomarkers, diagnostics, and drug development.

Founded as a spin-off from the University of Brussels (VUB) in 2010 with a decade of top-level academic research as its foundation, PharmaFluidics aims to increase efficiency and resolution in liquid chromatography (LC) with ease of use and robustness, opening the way to further miniaturization and integration. 

The company confirmed much of the funds will be used to speed up the commercialization of its range of microchip‑based chromatography cartridges. The cartridges are designed for use in biomarker, diagnostics, and
drug research and development applications across biotechnology and pharmaceutical industries. The remaining funds will be used to develop new application fields and reference cases, to broaden the market beyond the current pioneer users.

“These micro-chip columns have an immediate design and performance appeal to pioneer users in the pharmaceutical research and development segment,” said Johan Devenyns, Managing Director of PharmaFluidics. “We believe that ‘secondary features’ such as convenience of use, workflow simplification, column longevity and robustness, and reduced solvent consumption will allow for the future generations of microchip columns and cartridges to gain substantial market share. There is also a bright future for microchip-based columns to be used in combination with simplified, lower cost MS systems, which will become affordable in many more settings and places,” he added

PharmaFluidics also announced a presentation by Johan Devenyns at the “Knowledge for Growth” conference on 18 May 2017 in Ghent, Belgium. 

The presentation will discuss micro-chip, pillar array columns, and monolithic chromatography separation beds and present examples of cell tryptic digests and plant tissue extracts to demonstrate the potential of the micro-chip technology. - L.B. 

For more information on PharmaFluidics please visit: www.pharmafluidics.com

For more information on the “Knowledge for Growth” conference please visit: www.knowledgeforgrowth.be/en